Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Allen Cohn, MD
US Oncology Research
Principal Investigator - Leonard Saltz, M.D.
Memorial Sloan Kettering Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
82 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Brimingham Hematology and Oncology
Birmingham, Alabama, United States
- Hematology Oncology Associates
Phoenix, Arizona, United States
- Northern Az Hematology & Oncology Assoc
Sedona, Arizona, United States
- Business Office - Acrc
Tucson, Arizona, United States
- Cancer Care Associates of Fresno Medical Group, Inc (aka California Cancer Care)
Fresno, California, United States
- Monterey Bay Oncology
Monterey, California, United States
- Rocky Mountain Cancer Center-Midtown
Denver, Colorado, United States
- Greeley Medical Clinic Oncology Hematology, Pc
Greeley, Colorado, United States
- Connecticut Oncology & Hematology, Llp
Torrington, Connecticut, United States
- Integrated Community Oncology Network (icon) / Fka:florida Oncology Associates
Jacksonville, Florida, United States
- Melbourne Internal Medicine Associates
Melbourne, Florida, United States
- Florida Cancer Institute
New Port Richey, Florida, United States
- Ocala Oncology Center
Ocala, Florida, United States
- Cancer Centers of Florida, P.A.
Ocoee, Florida, United States
- Medical Oncology Associates of Augusta Pc
Augusta, Georgia, United States
- Spalding Oncology Services
Griffin, Georgia, United States
- Hematology Oncology Associates of Il
Chicago, Illinois, United States
- Cancer Care & Hematology Specialists of Chicagoland
Niles, Illinois, United States
- Fort Wayne Medical Oncology Hematology, Inc
Fort Wayne, Indiana, United States
- Central Indiana Cancer Centers
Indianapolis, Indiana, United States
- Hope Center
Terre Haute, Indiana, United States
- Iowa Blood and Cancer Care
Cedar Rapids, Iowa, United States
- Kansas City Cancer Centers-Southwest
Overland Park, Kansas, United States
- Cancer Center of Kansas
Wichita, Kansas, United States
- Louisiana Hematology Oncology Associates
Baton Rouge, Louisiana, United States
- Auerbach Hematology Oncology Associated
Baltimore, Maryland, United States
- Center for Cancer & Blood Disorders
Bethesda, Maryland, United States
- Maryland Oncology Hematology, P.A.
Columbia, Maryland, United States
- Osteopathic Medical Oncology and Hematology
Clinton Township, Michigan, United States
- Kalamazoo Hematology & Oncology
Kalamazoo, Michigan, United States
- Hematology Oncology Associates of Ohio & Michigan
Lambertville, Michigan, United States
- Minnesota Oncology Hematology, Pa
Minneapolis, Minnesota, United States
- Missouri Cancer Associates
Columbia, Missouri, United States
- Comprehensive Cancer Centers of Nevada
Las Vegas, Nevada, United States
- Nevada Cancer Centers
Las Vegas, Nevada, United States
- Hematology-Oncology Associates of Nnj, Pa
Morristown, New Jersey, United States
- New York Oncology Hematology, Pc
Albany, New York, United States
- North Shore Hematology
East Setauket, New York, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- Raleigh Hematology Oncology Associates
Cary, North Carolina, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2005
- Primary completion
- 30 Jun 2007
- Completion
- 30 Jun 2009
- Last update posted
- 15 Feb 2019
- Registered enrollment
- 247
- Registry id
- NCT00252564
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.